Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance.
- NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_assertion description "[Targeted proteins, associated with different signal transduction pathways, have included transforming growth factor-alpha [TGF-alpha (MR(1))], its binding site the epidermal growth factor receptor [EGFR (MR(2))] sharing sequence homology to the breast cancer prognostic marker Her-2/neu, an apoptosis inhibiting protein [bcl-2 (MR(4))], and the androgen receptor [AR (MR(5))].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance.
- NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_assertion evidence source_evidence_literature NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance.
- NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_assertion SIO_000772 18686047 NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance.
- NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_assertion wasDerivedFrom befree-20140225 NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance.
- NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_assertion wasGeneratedBy ECO_0000203 NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP329943.RAtHDMF2TupBsT9GrLjyslAJtwfNSNzY_gi70LW0FmbwA130_provenance.